Apimeds Pharmaceuticals US, Inc. (APUS) is listed on NYSE American in the Manufacturing sector. This page tracks real-time APUS price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 60.2 Near Overbought
Market Cap $70.9M
Volume 49.3K
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $-35.1M
EPS $-2.26
P/E Ratio -2.1x
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Kim Christopher | Chairman and CMO | Buy | 27,500 | $1.83 | $50,359 | 2025 May 14 |
| Koo Jakap | Director | Buy | 28,500 | $1.99 | $56,715 | 2025 May 12 |
| Inscobee Inc. | 10% Owner | Buy | 500,000 | $4.00 | $2.0M | 2025 May 12 |
Take APUS further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put APUS in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Apimeds Pharmaceuticals US, Inc. next reports.
Set alerts on APUS
Get notified when Apimeds Pharmaceuticals US, Inc. hits your price targets or technical conditions are met.
Get Started Free